Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Peri S. Aytac"'
Autor:
Deniz Cansen Kahraman, Ebru Bilget Guven, Peri S. Aytac, Gamze Aykut, Birsen Tozkoparan, Rengul Cetin Atalay
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Hepatocellular carcinoma (HCC) is a highly heterogeneous cancer, and resistant to both conventional and targeted chemotherapy. Recently, nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to decrease the incidence and mortality of
Externí odkaz:
https://doaj.org/article/de9102c153df4f01a413d6729442aabf
Autor:
Deniz Cansen Kahraman, Ebru Bilget Guven, Peri S. Aytac, Gamze Aykut, Birsen Tozkoparan, Rengul Cetin Atalay
Hepatocellular carcinoma (HCC) is a highly heterogeneous cancer, and resistant to both conventional and targeted chemotherapy. (NSAIDs) Recently, nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to decrease the incidence and mortality of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3c57a6f7d08b57c4d8523b389bbb2a4
https://doi.org/10.21203/rs.3.rs-1025268/v1
https://doi.org/10.21203/rs.3.rs-1025268/v1
